Industry News | tctmd.com

News Industry News

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

July 22, 2015

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Industry News

Blue Cross Blue Shield Association Study Reveals Significant Cost Variations for Angioplasties

July 17, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Industry News

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

September 16, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

Subscribe to Industry News

Advertisement

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

Blue Cross Blue Shield Association Study Reveals Significant Cost Variations for Angioplasties

QT Vascular Announces The Allowance Of Four New Patents

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content